ArticleCancer reports (Hoboken, N.J.)2026
Clinicopathological Features, Treatment Patterns, and Long-Term Survival in Patients With Testicular Cancer: A Retrospective Cohort Study.
Article in Cancer reports (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundTesticular cancer represents the most common solid tumor in young adult males and is associated with excellent long-term survival outcomes.
aimThe aim of this study is to evaluate clinical and pathological characteristics, treatment strategies, and survival outcomes of a large Romanian institutional cohort. METHODS AND
resultsWe conducted a retrospective study including 246 patients with testicular cancer treated at a tertiary oncology center between January 2005 and December 2015. Clinical, pathological, and treatment data were extracted from institutional medical records, and survival outcomes were obtained from administrative registries. Overall survival was estimated using the Kaplan-Meier method and compared between groups using the log-rank test. Cox proportional hazards regression was used to estimate adjusted hazard ratios with 95% confidence intervals. The study included 246 patients, with a mean age at diagnosis of 32.3 years. Non-seminomatous mixed germ cell tumors were the most frequent histological subtype, followed by seminoma. Stage I disease was the most common presentation, while approximately one-third of patients had advanced disease. At last follow-up, 210 patients (85.4%) were alive. Survival was significantly better in early-stage disease and worse among patients with advanced stage and poor IGCCCG risk.
conclusionIn this Romanian cohort, nearly one-third of patients with testicular cancer presented with advanced-stage disease, and non-seminomatous tumors were the most frequent histological type. Long-term outcomes were excellent for stage I-II disease, while advanced stage and poor IGCCCG risk were associated with worse survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.